Strides receives USFDA approval for Triamcinolone Acetonide Ointment EP News Bureau Jun 2, 2020 Product approval from flagship facility in Bangalore, to be marketed by Strides Pharma in the US
Strides receives USFDA tentative approval for Triamcinolone Acetonide ointment EP News Bureau Jan 27, 2020 Product approval from flagship facility in Bengaluru; to be marketed by Strides Pharma Inc. effective May 30,2020
Strides Pharma arm gets tentative USFDA nod for skin ointment Press Trust of India Jan 24, 2020 The product will be manufactured at the company's oral dosage facility at Bengaluru and will be marketed by Strides Pharma Inc in…
